| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Matthew D Snape | Q55456266 |
| Jonathan Broad | Q88161716 | ||
| Sophie Janet | Q89451820 | ||
| P2093 | author name string | Jonathan Broad | |
| Sophie Janet | |||
| P2860 | cites work | Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study | Q24806002 |
| Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis | Q29619821 | ||
| H1N1 2009 influenza virus infection during pregnancy in the USA. | Q30379409 | ||
| The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya | Q30941156 | ||
| Respiratory syncytial virus: seasonal data for regions of Florida and implications for palivizumab | Q31119223 | ||
| Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator | Q40997472 | ||
| Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats | Q41026321 | ||
| Effectiveness of maternal pertussis vaccination in England: an observational study. | Q42205386 | ||
| Respiratory syncytial virus infection as a cause of hospitalization in population under 1 year in Colombia | Q42270177 | ||
| Seasonal variation in respiratory syncytial virus infections in children in Benin-City, Nigeria | Q44132427 | ||
| The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus | Q44179222 | ||
| Epidemiology of respiratory syncytial virus infection among paediatric patients in Hong Kong: seasonality and disease impact | Q44851611 | ||
| Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus | Q45387257 | ||
| Temperature, humidity, and ultraviolet B radiation predict community respiratory syncytial virus activity | Q45398576 | ||
| Climatic factors and lower respiratory tract infection due to respiratory syncytial virus in hospitalised infants in northern Spain | Q45457590 | ||
| Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection | Q45763369 | ||
| Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level | Q45792098 | ||
| Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population | Q45823296 | ||
| Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine | Q45823297 | ||
| Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm Infants | Q49720574 | ||
| Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England. | Q53693691 | ||
| Maternal and neonatal tetanus | Q61037962 | ||
| Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group | Q77300551 | ||
| Climatic, temporal, and geographic characteristics of respiratory syncytial virus disease in a tropical island population. | Q33313430 | ||
| A novel six consecutive monthly doses of palivizumab prophylaxis protocol for the prevention of respiratory syncytial virus infection in high-risk preterm infants in Taiwan | Q33817471 | ||
| Residential crowding and severe respiratory syncytial virus disease among infants and young children: a systematic literature review | Q34240719 | ||
| Prolonged seasonality of respiratory syncytial virus infection among preterm infants in a subtropical climate | Q34379517 | ||
| Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review | Q34606237 | ||
| Safety and Effectiveness of Palivizumab in Children at High Risk of Serious Disease Due to Respiratory Syncytial Virus Infection: A Systematic Review | Q34726169 | ||
| Respiratory syncytial virus epidemics: the ups and downs of a seasonal virus | Q35097189 | ||
| Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh | Q35102554 | ||
| Risk factors for hospital admission with RSV bronchiolitis in England: a population-based birth cohort study | Q35106819 | ||
| Evaluating vaccination strategies for reducing infant respiratory syncytial virus infection in low-income settings | Q35213237 | ||
| Clinical Presentation and Birth Outcomes Associated with Respiratory Syncytial Virus Infection in Pregnancy | Q35975363 | ||
| Maternal Effects of Respiratory Syncytial Virus Infection during Pregnancy | Q36212079 | ||
| Admission to hospital for bronchiolitis in England: trends over five decades, geographical variation and association with perinatal characteristics and subsequent asthma | Q36577321 | ||
| The viral etiology of acute respiratory infections in children in Uganda | Q36630744 | ||
| Maternal Immunization Earlier in Pregnancy Maximizes Antibody Transfer and Expected Infant Seropositivity Against Pertussis | Q36676385 | ||
| Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection | Q37212728 | ||
| Vaccination strategies against respiratory syncytial virus | Q37469280 | ||
| Estimating the burden of respiratory syncytial virus (RSV) on respiratory hospital admissions in children less than five years of age in England, 2007-2012. | Q37638405 | ||
| Safety, Tolerability, and Pharmacokinetics of MEDI8897, the Respiratory Syncytial Virus Prefusion F-Targeting Monoclonal Antibody with an Extended Half-Life, in Healthy Adults | Q37669850 | ||
| The relationship between RSV bronchiolitis and recurrent wheeze: the chicken and the egg. | Q37835953 | ||
| Effects of influenza on pregnant women and infants | Q38037607 | ||
| Correlations between climate factors and incidence--a contributor to RSV seasonality. | Q38178221 | ||
| Systematic review and meta-analysis of respiratory syncytial virus infection epidemiology in Latin America. | Q38206527 | ||
| Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization: Secondary Analysis of a Randomized Clinical Trial | Q38390492 | ||
| Advances in RSV vaccine research and development - A global agenda | Q38815042 | ||
| Seasonal trends of viral respiratory tract infections in the tropics | Q38943792 | ||
| Time series analysis of RSV and bronchiolitis seasonality in temperate and tropical Western Australia. | Q39071295 | ||
| Acute bronchiolitis in tropical Africa: a hospital-based perspective in Ibadan, Nigeria | Q39108661 | ||
| Acute lower respiratory tract infection due to virus among hospitalized children in Dhaka, Bangladesh | Q39260313 | ||
| A community-based study of acute respiratory tract infection in Thai children | Q39264549 | ||
| Respiratory syncytial virus infection and prevalence of subgroups A and B in Hawaii | Q39389648 | ||
| Respiratory syncytial virus infection in tropical and developing countries | Q39583202 | ||
| Chronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States | Q40060039 | ||
| Effectiveness of maternal influenza immunization in mothers and infants | Q40409398 | ||
| Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women | Q40555244 | ||
| Respiratory syncytial virus infections in previously healthy working adults | Q40597674 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 234-244 | |
| P577 | publication date | 2017-12-15 | |
| P1433 | published in | Human Vaccines & Immunotherapeutics | Q21072749 |
| P1476 | title | Respiratory syncytial virus seasonality and its implications on prevention strategies | |
| P478 | volume | 14 |
Search more.